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The protein kinases p38γ and p38δ belong to the p38 mitogen-activated protein kinase
(MAPK) family. p38MAPK signaling controls many cellular processes and is one of the
most conserved mechanisms in eukaryotes for the cellular response to environmental
stress and inflammation. Although p38γ and p38δ are widely expressed, it is likely
that they perform specific functions in different tissues. Their involvement in human
pathologies such as inflammation-related diseases or cancer is starting to be uncovered.
In this article we give a general overview and highlight recent advances made in defining
the functions of p38γ and p38δ, focusing in innate immunity and inflammation. We
consider the potential of the pharmacological targeting of MAPK pathways to treat
autoimmune and inflammatory diseases and cancer.
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INTRODUCTION
The activation of p38 Mitogen Activated Protein Kinases (p38MAPKs) is one of the main signal
transduction mechanisms by which the cell adapts to changes in the environment. There are four
p38MAPK isoforms inmammalian cells encoded by different genes: p38α (MAPK14), p38β (MAPK
11), p38γ (MAPK 12), and p38δ (MAPK 13) (Cuenda and Rousseau, 2007). p38α was the first
p38MAPK family member identified, therefore the most studied and best-characterized isoform;
most of the literature on p38MAPK refers to p38α.
The four p38MAPK isoforms are widely expressed, but their expression pattern varies in tissues.
p38α is ubiquitously expressed in all cell types and tissues, although expression levels are lower in
the brain, liver, and pancreas than in other tissues. p38β is highly expressed in the brain, thymus,
and spleen; its expression is lower in the adrenals, lung, kidney, liver, pancreas, and heart, and it is
not expressed in skeletal muscle (Beardmore et al., 2005). p38γ is very abundant in skeletal muscle,
although its expression in most other tissues is lower (Mertens et al., 1996; Beardmore et al., 2005).
p38δ levels are high in pancreas, intestine, adrenal gland, kidney, and heart (Goedert et al., 1997;
Jiang et al., 1997; Beardmore et al., 2005).
p38MAPKs are strongly activated by a wide variety of environmental and cellular stresses
or by inflammatory cytokines, but are poorly activated by serum or growth factors (Cuenda
and Rousseau, 2007). All p38MAPKs are Serine/Threonine kinases that catalyze the reversible
phosphorylation of proteins. They are activated by dual phosphorylation of the TGY activation
motif mediated by the MAPK kinases (MAP2K) MKK3, and MKK6, and in the case of p38α
also by MKK4 (Remy et al., 2010). The activation of distinct p38MAPK isoforms is regulated
by the selective and synchronized action of two kinases, MKK3 and MKK6. These two MAP2Ks
Escós et al. p38γ and p38δ MAPK
are implicated in p38α, p38γ, and p38β activation in response to
general environmental stresses in mouse embryonic fibroblasts
(Remy et al., 2010). However, MKK3 is the major kinase
responsible for p38δ activation (Remy et al., 2010). MKK3
and MKK6 are in turn activated upon phosphorylation of
Serine/Threonine residues by a MAPK kinase kinase (MAP3K).
Several MAP3Ks, includingMAPK/ERK kinase kinases (MEKK),
TAO1 and 2, ASK1 (apoptosis signal-regulating kinase-1), MLKs
(mixed-lineage kinases), and TAK1 (TGF β-activated kinase 1)
activate p38MAPK cascade; the specific MAP3K that is required
appears to be stimulus and cell type specific (Cuenda and
Rousseau, 2007) (Figure 1).
p38MAPK family can be further divided into two subsets,
p38α/p38β and p38γ/p38δ, based on sequence homology,
substrate specificities, and sensitivity to chemical inhibitors. In
this review, we provide an overview of p38γ and p38δ (also called
alternative p38MAPKs), which play important roles in the innate
immune response, in inflammation and inflammation-related
diseases such as cancer or arthritis.
GENERAL FEATURES OF p38γ AND p38δ
SIGNALING PATHWAYS
One of the hallmarks used for the division of p38MAPK into
two subgroups is the protein sequence similarity. p38γ and p38δ
sequences are highly similar to each other (∼70% identity),
whereas p38α and p38β display higher similarity (75% identity).
In contrast, p38γ and p38δ are more divergent in sequence to
p38α (∼60% identical to p38α) (Risco and Cuenda, 2012). These
two p38MAPK subgroups also differ on their sensitivity to kinase
inhibitors. Pharmacological experiments demonstrated that only
p38α and p38β are inhibited by certain compounds, which
are ATP competitors, such as SB203580 and other pyridinyl
imidazoles, whereas p38γ and p38δ are not affected by these
drugs (Goedert et al., 1997; Kuma et al., 2005; Bain et al., 2007).
However, the diaryl urea compound BIRB796, a molecule that
functions allosterically and is a potent inhibitor of p38α and
p38β, also inhibits p38γ and p38δ at higher concentrations in
cell-based assays. This compound has provided a good tool for
identifying physiological substrates and roles of the alternative
p38MAPK isoforms (Kuma et al., 2005; Cuenda and Rousseau,
2007; Risco and Cuenda, 2012). Nonetheless, due to the lack
of specific p38γ and p38δ inhibitors, the information about
the physiological substrates and the biological function of these
kinases is limited compared to the extensive knowledge of p38α
functions.
The use of kinase inhibitors and the genetic deletion of
specific p38MAPK isoforms has showed that they have some
overlapping substrates and functional redundancy; however,
there are particular proteins that are better substrates for
p38α/p38β than for p38γ/p38δ and the other way around (Kuma
et al., 2005; Cuenda and Rousseau, 2007; Risco and Cuenda,
2012). Even more, protein kinases such as MAPK-activated
protein kinase 2 (MK2) or MK3 are good substrates for p38α and
p38β, but cannot be phosphorylated by other p38MAPK isoforms
(Cuenda et al., 1997; Goedert et al., 1997; Cuenda and Rousseau,
2007; Arthur and Ley, 2013) (Figure 1).
It has been reported that p38δ kinase phosphorylates the
neuronal microtubule-associated protein Tau (Feijoo et al., 2005),
the eukaryotic elongation factor 2 kinase (eEF2K) (Knebel et al.,
2001), the protein kinase D1 (PKD1) (Sumara et al., 2009),
which controls insulin exocytosis in pancreatic beta cells and
chemotaxis in neutrophils, and the signal adaptor p62, which
controls mTORC1 activation, autophagy, and tumor growth
(Linares et al., 2015).
Several physiological substrates for p38γ have been described
taking advantage of a feature that makes p38γ unique among
other MAPKs. p38γ possesses a short C-terminal sequence
(-KETXL), which binds to PDZ domains. p38γ associates with
PDZ-domain containing proteins, such as α1-syntrophin, SAP
(synapse-associated protein) 90/PSD (post-synapse density) 95,
hDlg (human disc large also known as SAP97) and the protein
tyrosine phosphatase PTPH1 and under stress conditions it
is able to phosphorylate them and modulate their activity
(Hasegawa et al., 1999; Sabio et al., 2004, 2005; Hou et al.,
2010). For example, changes in the osmolarity of the environment
trigger p38γ activation in the cytoplasm, which phosphorylates
hDlg. Phosphorylation of hDlg leads to its dissociation from
the cytoskeletal guanylate kinase-associated protein (GKAP) and
therefore from the cytoskeleton (Hasegawa et al., 1999; Sabio
et al., 2004, 2005; Hou et al., 2010). In addition, the interaction
of p38γ with the single PDZ domain of PTPH1 enables this
phosphatase to dephosphorylate p38γ, but not p38α, in vitro
and in cells over-expressing both proteins (Hou et al., 2010;
Chen et al., 2014). So far, the only physiological p38γ substrate
that does not require PDZ domain binding interactions is the
transcription factor MyoD, whose phosphorylation by p38γ
results in a decrease in its transcriptional activity (Gillespie et al.,
2009).
p38MAPKs act normally by direct phosphorylation of
substrates on Serine or Threonine residues followed by
Proline, however, there are some examples showing that p38α
and also p38γ may also have kinase independent roles by
associating to protein targets and modulating their function
in the absence of phosphorylation (reviewed in Cuadrado and
Nebreda, 2010; Risco and Cuenda, 2012). For example, it has
been shown that p38γ regulates nuclear protein complexes
independently of its kinase activity. Changes in the osmolarity
cause the accumulation of p38γ in the nucleus where it
interacts with nuclear hDlg. In the nucleus, hDlg forms a
complex with the proteins polypyrimidine tract-binding (PTB)
protein-associated splicing factor (PSF) and p54nrb, and with
various RNAs. p38γ regulates hDlg-PSF complex dissociation
independently of hDlg phosphorylation by displacing PSF
from hDlg, since both proteins, p38γ and PSF, bind to
PDZ1 domain of hDlg. This has been shown comparing
cells from knockin mice expressing an endogenous kinase-
inactive p38γ mutant with cells from mice lacking p38γ
(Sabio et al., 2005, 2010; Remy et al., 2010; Risco and
Cuenda, 2012). The studies on p38γ-hDlg-GKAP and p38γ-
hDlg-PSF protein complexes indicate that, through its ability
to shuttle between cytoplasm and nucleus, p38γ might provide
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FIGURE 1 | p38MAPK pathways consist of several MAPK kinase kinases (MAP3K), three MAPK kinase (MAP2K), and four p38MAPK. These pathways
can be activated by many stimuli, including growth factors, inflammatory cytokines, and a wide range of cellular stresses. The p38MAPKs phosphorylate different
substrates, including protein kinases, cytosolic substrates, and transcription factors. ASK1 (apoptosis signal-regulating kinase-1), eEF2K (eukaryotic elongation factor
2 kinase), hDlg (human disc large), MEKK (MAPK/ERK kinase kinases), MK (MAPK-activated protein kinase), MLKs (mixed-lineage kinases), MNK (MAPK-interacting
protein kinase), MSK (mitogen and stress-activated kinase), PKD1 (protein kinase D1), PSD95 (post-synapse density 95), PTPH1 (protein tyrosine phosphatase H1),
TAK1 (TGF β-activated kinase 1), TAO (thousand-and-one amino acid).
a connection between two processes critical for adaptation
to environmental changes: gene expression and cytoskeletal
reorganization.
SOME PHYSIOLOGICAL ROLES OF p38γ
AND p38δ MAPK PATHWAYS
Studies using knock-out mice have provided important
information concerning p38γ and p38δ functions in vivo and in
pathological conditions (Figure 2). p38γ and p38δ deficient mice
are viable and have not apparent phenotypes (Sabio et al., 2005,
2010; Remy et al., 2010; Risco and Cuenda, 2012). Nonetheless,
there are reports showing the implication of p38γ and p38δ
in tissue regeneration, cancer, and metabolic diseases (Sabio
et al., 2005, 2010; Remy et al., 2010; Risco and Cuenda, 2012).
Thus, it has been described that p38δ regulates insulin secretion
and pancreatic β cells death implying a central role in diabetes
(Cuenda and Nebreda, 2009; Sumara et al., 2009). p38δ is also
crucial in neutrophil chemotaxis pathway, contributing to acute
respiratory distress syndrome (ARDS) (Ittner et al., 2012), and in
mediating IL-13-driven mucus overproduction in human airway
epithelial cells in chronic inflammatory lung diseases (Alevy
et al., 2012).
Since p38γ expression is very high in skeletal muscle and
its expression is induced during muscle differentiation (Cuenda
and Cohen, 1999; Tortorella et al., 2003; Perdiguero et al.,
2007), it is not surprising that it plays a fundamental role in
this process. Thus, p38γ knockdown impairs cardiomyocyte
formation (Ramachandra et al., 2016) and p38γ and p38δ
promote cardiac hypertrophy by modulating the mTOR pathway
(González-Terán et al., 2016). Moreover, studies in p38γ
deficient mice reported that p38γ plays a pivotal role in
blocking the premature differentiation of skeletal muscle
stem cells, the satellite cells that participate in adult muscle
regeneration (Gillespie et al., 2009). Also, p38γ is required for
the upregulation of PGC-1α [peroxisome proliferator-activated
receptor-γ (PPARγ) coactivator-1α] in mitochondrial biogenesis
and angiogenesis in response to endurance exercise in mice,
which is critical for skeletal muscle adaptation (Pogozelski et al.,
2009).
In addition, p38γ and p38δ are involved in the modulation of
some processes implicated in cellular malignant transformation,
such as proliferation, cell cycle progression, apoptosis, or cell
migration. Usingmouse embryonic fibroblasts derived frommice
lacking p38γ or p38δ, it has been shown that deletion of either
p38γ or p38δ increases cell migration and metalloproteinase-
2 secretion, whereas only p38δ deficiency impairs cell contact
inhibition. Also, lack of p38γ in K-Ras-transformed fibroblasts
leads to increased cell proliferation as well as tumorigenesis
both in vitro and in vivo (Cerezo-Guisado et al., 2011). These
pieces of evidence indicates that p38γ and p38δ have a role in
tumor suppression; however, there are other studies reporting
a pro-oncogenic function for these kinases, for example in the
development of breast and skin cancer (reviewed in Risco and
Cuenda, 2012).
p38γ AND p38δ IN THE INNATE RESPONSE
AND IN INFLAMMATION
The use of genetically modified mice lacking one or more p38
isoform has provided strong evidence of the p38γ and p38δ
importance in the innate immune response and in inflammation
(Figure 2). The innate immune system is the front line of defense
against invading pathogens, and uses evolutionarily conserved
high-affinity receptors (pattern recognition receptors, PRRs) that
recognize specific constituents of bacteria or virus, endogenous
cytokines and host cell-derived components (Kawai and Akira,
2007). The activation of PRRs in the innate immune cells leads to
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FIGURE 2 | Physiological roles and pathological implications of p38γ and p38δ. p38γ and p38δ are key players in the regulation of many biological functions,
which contribute to physiological processes. Deregulation of p38γ and p38δ leads to the development of several pathological conditions.
secretion of inflammatory cytokines and other mediators, which
induce an inflammatory response. This inflammatory response
promotes the recruitment of additional immune cells, the
elimination of infectious agents, and the induction of tissue repair
(Kawai and Akira, 2007). The production of cytokines during the
innate response is also important for the subsequent induction of
the adaptive immune response (Iwasaki and Medzhitov, 2010).
The stimulation of all PRRs by pathogen-associated molecules
activates both MAPKs and NFκB pathways, which are crucial
to generate immune responses (Cuenda and Rousseau, 2007;
Gaestel et al., 2009; Arthur and Ley, 2013).
The important role of the MAPK p38α in the innate immune
response and in inflammation has been uncovered mainly by
studies using a range of p38α inhibitors or the constitutive
deletion of its physiological substrates, or activators (Cuenda
and Rousseau, 2007; Gaestel et al., 2009; Arthur and Ley,
2013). Much less is known about the importance of p38γ and
p38δ in these processes. However, recent studies show that in
macrophages and dendritic cells (DC), which are key mediators
of the inflammatory response, the deletion of both p38γ and
p38δ impaired the innate immune response to lipopolysaccharide
(LPS), a Toll-like receptor 4 (TLR4) ligand (Risco et al., 2012).
In these cells p38γ and p38δ are necessary to maintain steady-
state levels of TPL-2, the MKK kinase that mediates ERK1/2
activation in response to TLR stimulation (Gantke et al., 2011).
ERK1/2 are other MAPK family members that play a central role
in cytokine production. p38γ and p38δ deficient macrophages
(p38γ/δ−/−) showed substantially lower levels of TPL2 protein,
and therefore lower MKK1-ERK1/2 activation and inflammatory
cytokine production (Risco et al., 2012). Exogenous expression
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of TPL-2 in p38γ/δ−/− macrophages not only increased ERK1/2
activation, but also rescued TPL-2-dependent TNFα production
in response to LPS (Risco et al., 2012).
p38γ and p38δ signaling has complex pro- and anti-
inflammatory effects on cytokine production in innate immune
responses. Production of TNFα, IL-1β, and IL-10 is severely
reduced in LPS-stimulated macrophages from p38γ/δ-deficient
mice, whereas IL-12 and IFNβ production increases (Risco et al.,
2012). p38γ and p38δ regulate IL-1β and IL-10 production
at the transcriptional level, whereas regulation of TNFα is
at the secretion level in bone marrow derived macrophages
stimulated with LPS (Risco et al., 2012). In LPS-stimulated liver
macrophages, p38γ and p38δ are required for the translation
of Tnf mRNA through inhibitory phosphorylation of eEF2K
that leads to activation of eEF2 (González-Teran et al., 2013).
Furthermore, in TPA-stimulated keratinocytes, p38γ and p38δ
are required for IL-6, IL-1β, and CXCL1 transcription (Zur et al.,
2015). The exact mechanisms by which p38γ and p38δ regulate
the production of cytokines and chemokines in different cells are
still largely unknown and further studies are needed to determine
them.
Using p38δ deficient mice it has been shown that this
p38MAPK isoform is important in neutrophils migration
and in their recruitment into inflammatory sites in lung
(Ittner et al., 2012). The degree of inflammation and the
associated organ damage is a consequence of complex pro-
and anti-inflammatory responses, which involve the regulation
of neutrophil recruitment and migration in a cell-autonomous
manner. p38δ-deficient neutrophils show a defect in chemotaxis,
which is caused by increased activity of the p38δ substrate, the
kinase PKD1 (Sumara et al., 2009). PKD1 phosphorylates p85α
to enhance its interaction with PTEN, leading to increased PTEN
activity and lower cell migration (Ittner et al., 2012). Appropriate
signaling in neutrophils is essential to resolve inflammation
without causing inappropriate organ damage.
Overall, these data strongly suggest that p38γ and p38δ have a
key role in the mechanisms leading to inflammation.
p38γ AND p38δ IN INFLAMMATORY
DISEASES
The role of p38γ and p38δ in inflammation in vivo is further
supported by experiments in other mouse animal models. The
reaction to bacterial LPS is a well-characterized innate immune
response that leads to endotoxic or septic shock, due primarily
to TNFα overproduction. Thus, p38γ/δ-deficient mice are less
sensitive to endotoxic shock than wild type mice following
LPS challenge and this is associated with a decrease in serum
levels of inflammatory cytokines such as TNFα, IL-1β, or IL-
10 (Risco et al., 2012). The acute liver failure caused by LPS
is also suppressed in mice that lack p38γ and p38δ in myeloid
cells (González-Teran et al., 2013). In addition, p38δ deletion
results in decreased alveolar neutrophil accumulation, reduces
acute lung inflammation, and protect from acute lung injury
(ALI) induced by LPS (Ittner et al., 2012). Also, there are evidence
that p38δ mediates mucus production in chronic inflammatory
lung disease, since either the knockdown or inhibition of p38δ,
but not of p38α, can block inflammatory IL13-induced mucus
production in human airway epithelial cells (Alevy et al., 2012).
The role of p38γ and p38δ isoforms in other inflammatory
diseases such as arthritis has recently been shown in a collagen-
induced arthritis (CIA) mouse model. Combined p38γ and p38δ
deficiency markedly reduced arthritis severity by suppressing
clinical disease and bone destruction, compared with that in wild
type mice (Criado et al., 2014). p38γ/δ deficient mice have lower
mRNA expression of IL-17 and IFNγ in joints, and lower levels
of pathogenic anti-collagen antibodies, IL-1β, and TNF-α in the
serum than wild type mice (Criado et al., 2014). p38γ and p38δ
also seem to control T cell activation, for example lymph node
T cells from p38γ/δ-deficient mice show reduced proliferation
and interferon (IFN)γ and IL-17 production (Criado et al.,
2014). Moreover, p38γ/δ deficient mice showed a lower Th17
cell frequency and a greater Treg/Th17 ratio, both of which are
linked to successful therapy in rheumatoid arthritis. The crucial
role of p38γ/δ in synovial inflammation, bone erosion, as well
as cytokine production suggests that they could serve as targets
of therapy in rheumatoid arthritis as an alternative to traditional
p38α inhibitors, which have provenminimally effective in human
disease (Gaestel et al., 2009; Arthur and Ley, 2013).
During the last few years the role of p38γ and p38δ in
cancer associated with chronic inflammation has been studied.
Chronic inflammation is linked with an increase in malignant
disease. Almost 20% of human cancers are related to chronic
inflammation caused by infections, exposure to irritants or
autoimmune diseases (Hanahan and Weinberg, 2011; Crusz and
Balkwill, 2015). Colitis-associated cancer (CAC) is a colon cancer
subtype associated with inflammatory bowel disease, such as
that occurring in ulcerative colitis or Crohn’s disease. Using
the azoxymethane (AOM)/dextran sodium sulfate (DSS) mouse
model of CAC it has been shown that p38γ and p38δ have a pro-
oncogenic role by regulating inflammatory signaling to promote
colon tumorigenesis, thus linking inflammation and cancer in
CAC (Del Reino et al., 2014). Mice deficient in p38γ and p38δ
display a decrease in cytokines and chemokines production and
in inflammatory cell infiltration in the colon of treated animal
and produce fewer colon tumors than control mice (Del Reino
et al., 2014). p38γ and p38δ in hematopoietic cells are important
for CAC development. Lethally irradiated wild type mice
reconstituted with bonemarrow from p38γ/δ-null mice exhibited
less tumor formation, cytokine production, and immune cell
infiltration, whereas p38γ/δ-deficient mice reconstituted with
wild type bone marrow showed more tumor formation, cytokine
production, and immune cell infiltration than controls (Del
Reino et al., 2014). The pro-oncogenic role of p38γ and p38δ was
also confirmed in the two-step 7,12-dimethylbenz(a)anthracene
(DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA) chemical
skin carcinogenesis model (Schindler et al., 2009; Zur et al., 2015).
p38γ/δ-deficient mice showed diminished cytokine production
and are resistant to tumorigenesis (Zur et al., 2015). Overall,
all of these results suggest potential therapeutic prospects by
targeting p38γ and p38δ for treatment of cancer. Future studies
examining the effects of cell type-selective p38γ and p38δ
targeting at different stages of carcinogenesis will elucidate
the functional roles of these two alternative p38MAPKs in
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the tumorigenesis process, and will guide future therapeutic
strategies.
CONCLUSION AND PERSPECTIVE
The role of p38γ and p38δ has been some times ignored since
most of the studies to date have focused on p38α, which is
the most abundant p38MAPK isoform. Nonetheless, in the last
years significant progress in understanding the functions of p38γ
and p38δ in vivo has been achieved. It is now clear that p38γ
and p38δ are crucial in innate response, inflammation, and
inflammatory diseases. Therefore, they deserve to be studied in
greater depth as they represent pharmacological target for the
development of drugs that might be useful for the treatment of
inflammatory pathologies. In fact, development of more specific
p38δ inhibitors has been shown to reduce mucus production in
human airway epithelial cells (Alevy et al., 2012). However, the
molecular mechanisms of how p38γ and p38δ regulate innate
response, including the significance of the regulation of other
signaling pathways components, cytokine production and the
recruitment of immune cells, remain to be fully established. A
better mechanistic understanding of p38γ/p38δ-regulated innate
response will permit the design of p38γ and p38δ-based therapies,
alternative to traditional p38α inhibitors, which have proven
minimally effective in human inflammatory diseases (Gaestel
et al., 2009; Arthur and Ley, 2013). The prospective that basic
research on p38γ and p38δ could be translated to the treatment
of human disease provides an exciting goal for future studies in
the field.
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